Far more complicated than that. Armstrong was identified early on as the candidate, but his brashness and arrogant attitude led him to be shipped out to France. It was the cancer that made him marketable. Weisel invested in far more than just Amgen, he also invested in companies linked to Nicomed Saluzar (Actovigen), as well as creating the US Cycling Foundation, investing heavily in US Cycling, putting members of his companies on the board. At one point most of the board of USC was made up of either sponsors of US Postal, Employees of Lances various companies, or board members on Wiesels companies.Maxiton said:Amgen and a principle investor, Weisel, identified competitive sport as a potentially huge avenue for profit, especially once they had taken a most unlikely canditate for sporting success - former cancer patient Armstrong - and used their drug to transform him into sporting superman. How far would they go to make this happen and maintain it? For the answers, you'll have to ask them. Or maybe we can just wait and let the investigators ask . . . .